- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
GODAVARIB
NSI
Week ended 07 Aug 2026
Weekly Investor Report
GODAVARI BIOREFINERIES L · Basic Materials · Chemicals
Latest close
246.9 INR
-5.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -14.3% below the Trend Line and sits at 15.6% of its 52-week range. The latest completed week returned -5.3%, after a -8.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
31
out of 100
Latest Close
246.9 INR
7 Aug 2026
1W Return
-5.3%
latest completed week
4W Return
-8.8%
short-term follow-through
12W Return
-17.3%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-5.3%
Latest completed week; four-week move -8.8%.
Indicator stack
31/32
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -14.3% below the Trend Line and sits at 15.6% of its 52-week range. The latest completed week returned -5.3%, after a -8.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1512-week average 0.51
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.8% over four weeks, -17.3% over 12 weeks, and -13.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.03Latest activity-pressure read.
Pressure change4.3%Four-week change in activity pressure.
Leadership-11.08Latest relative-leadership reading.
RS change-423.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength50/100Blend of value, momentum, and quality. Underlying universe rank 51; rank 1 is best.
Value71/100Relative valuation strength. Underlying universe rank 30; rank 1 is best.
Quality29/100Profitability and accounting quality. Underlying universe rank 72; rank 1 is best.
Momentum30/100Medium-term price momentum. Underlying universe rank 71; rank 1 is best.
Growth32/100Revenue and earnings growth. Underlying universe rank 69; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework32/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 358.3x Price divided by trailing earnings.
- Price / sales
- 0.6x Market value relative to trailing revenue.
- EV / EBITDA
- 16.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.1% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 28.2% Gross profit retained from each unit of revenue.
- Operating margin
- 3.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.1% Free cash flow generated from revenue.
- Return on invested capital
- 4.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 6.3% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 4.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 9 relevant articles.
1 positive · 7 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.0%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+12.4%Week of 20 Mar.
Worst week-11.6%Week of 29 May.
Latest week-5.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains8
Flat weeks0
Modest losses6
Sharp losses8
Recent vol5.5%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Chemicals
4-week rank38 / 40
Group average3.3%
Trend breadth77.5%
Trend77.5%active weekly trend signals
MD65.0%positive activity pressure
RS62.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape33/100
Trend, activity pressure, participation, and risk combine to a 33/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 3/12, activity pressure 2/12, relative leadership 7/12.
Activity pressure 0.15; No reversal markers Factors44/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 79; Small Cap Core rank 48 SVQF32/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1074.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 9 relevant articles.
Godavari Biorefineries Publishes Q1 FY2026 Unaudited Results in Newspapers Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 246.9 INR | -5.3% | 288.2 INR | 266.7 INR | -1.03 | -11.08 | 719.6K | Off |
| 31 Jul 2026 | 260.9 INR | -6.5% | 289.0 INR | 267.0 INR | -1.08 | -5.61 | 253.3K | Off |
| 24 Jul 2026 | 278.9 INR | 8.8% | 290.3 INR | 267.0 INR | -1.08 | 3.21 | 656.9K | Off |
| 17 Jul 2026 | 256.4 INR | -5.3% | 290.7 INR | 266.9 INR | -1.15 | -7.47 | 572.7K | Off |
| 10 Jul 2026 | 270.7 INR | -0.5% | 291.2 INR | 267.0 INR | -1.07 | -2.12 | 454.8K | Off |
| 3 Jul 2026 | 272.1 INR | -3.1% | 290.6 INR | 267.0 INR | -1.07 | -1.85 | 124.6K | Off |
| 26 Jun 2026 | 280.9 INR | -4.5% | 289.7 INR | 266.9 INR | -1.02 | 2.41 | 0 | Off |
| 19 Jun 2026 | 294.0 INR | 5.8% | 288.6 INR | 266.7 INR | -0.96 | 7.77 | 79.4K | Off |
| 12 Jun 2026 | 278.0 INR | 0.5% | 287.2 INR | 266.4 INR | -0.69 | 3.91 | 76.2K | Off |
| 5 Jun 2026 | 276.8 INR | -1.3% | 286.6 INR | 266.3 INR | -0.46 | 4.73 | 147.7K | On |
| 29 May 2026 | 280.5 INR | -11.6% | 285.8 INR | 266.2 INR | 0.08 | 5.41 | 1.4M | On |
| 22 May 2026 | 317.2 INR | 6.3% | 285.5 INR | 266.0 INR | 0.56 | 18.44 | 1.2M | On |
| 15 May 2026 | 298.5 INR | -4.6% | 283.7 INR | 265.4 INR | 0.87 | 12.91 | 781.9K | On |
| 8 May 2026 | 313.0 INR | -1.6% | 282.8 INR | 264.9 INR | 1.30 | 16.75 | 921.5K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.